The RETRIEVE Study: Use of the FiberNet® Embolic Protection System in Saphenous Vein Grafts

NCT00453518 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2009-08-18

No results posted yet for this study

Summary

This is a multicenter, prospective study designed to demonstrate the performance and safety of the FiberNet Embolic Protection System when used as an adjunctive device during saphenous vein graft (SVG) intervention.

Conditions

  • Saphenous Vein Graft Disease
  • Myocardial Ischemia
  • Embolism

Interventions

DEVICE

FiberNet EPS used during SVG intervention.

The FiberNet EPS is indicated for use as a guide wire and embolic protection system to capture and remove embolic material produced while performing percutaneous transluminal interventional procedures in saphenous vein grafts.

Sponsors & Collaborators

  • Lumen Biomedical

    lead INDUSTRY

Principal Investigators

  • Robert Feldman, MD · Munroe Regional Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00453518 on ClinicalTrials.gov